What is the recommended dose of Tamiflu (oseltamivir) for treating influenza?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosage of Tamiflu (Oseltamivir) for Treating Influenza

The recommended dose of Tamiflu (oseltamivir) for treating influenza in adults is 75 mg twice daily for 5 days, while dosing for children varies by weight and age. 1, 2

Adult Dosing

  • Adults and adolescents (≥13 years): 75 mg twice daily for 5 days 2, 1
  • Administration can be with or without food, though taking with food may improve gastrointestinal tolerability 2, 3
  • For patients with renal insufficiency (creatinine clearance 10-30 mL/min): 75 mg once daily for 5 days 2, 3

Pediatric Dosing

Weight-based dosing for children ≥12 months:

  • ≤15 kg (≤33 lb): 30 mg twice daily for 5 days 2, 1
  • 15-23 kg (33-51 lb): 45 mg twice daily for 5 days 2, 1

  • 23-40 kg (51-88 lb): 60 mg twice daily for 5 days 2, 1

  • 40 kg (>88 lb): 75 mg twice daily for 5 days 2, 1

Age-based dosing for infants:

  • Infants 9-11 months: 3.5 mg/kg per dose twice daily for 5 days 2
  • Term infants 0-8 months: 3 mg/kg per dose twice daily for 5 days 2
  • Preterm infants: Dosing based on postmenstrual age (gestational age + chronological age) 2, 3
    • <38 weeks postmenstrual age: 1.0 mg/kg twice daily 2
    • 38-40 weeks postmenstrual age: 1.5 mg/kg twice daily 2
    • 40 weeks postmenstrual age: 3.0 mg/kg twice daily 2

Formulation Information

  • Available as Tamiflu in 30 mg, 45 mg, and 75 mg capsules 2, 1
  • Also available as powder for oral suspension (6 mg/mL when reconstituted) 2, 1
  • If commercial suspension is unavailable, capsules can be opened and mixed with sweetened liquid or a suspension can be compounded by pharmacists 2

Clinical Considerations

  • Treatment should be initiated within 48 hours of symptom onset for maximum effectiveness 3, 4
  • Early initiation of therapy is associated with faster resolution of symptoms 4
  • Standard dosing is effective for both influenza A and B strains, though higher doses may improve virologic response specifically in influenza B infections 5
  • No significant benefit has been demonstrated for double-dose oseltamivir therapy in most patient populations 6
  • Treatment beyond 48 hours after symptom onset may still be beneficial in critically ill patients with H1N1 influenza requiring ICU admission 6

Common Side Effects

  • Gastrointestinal effects (nausea, vomiting, diarrhea) are the most common adverse events 3, 4
  • These side effects are typically mild and transient 4
  • Taking oseltamivir with food can reduce gastrointestinal side effects 3, 4

The most recent guidelines consistently recommend the standard 75 mg twice daily dose for adults and appropriate weight-based dosing for children, with treatment duration of 5 days for uncomplicated influenza 2, 1. This dosing regimen has been shown to effectively reduce the duration of illness by up to 1.5 days and decrease the severity of symptoms when initiated promptly 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Oseltamivir Dosage and Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

A prospective intervention study on higher-dose oseltamivir treatment in adults hospitalized with influenza a and B infections.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013

Research

Influenza treatment with oseltamivir outside of labeled recommendations.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.